Researcher
Paul Clement
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2006 → Today
Projects
1 - 7 of 7
- Evaluating the clinical utility of minimally-invasive cfDNA analysis for surveillance and early cancer detection in germline TP53 mutation carriersFrom1 Oct 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Aggressive salivary gland neoplasms: institutional-international collaborative evaluation of advances in clinical management and translational research into tumor biologyFrom11 Jan 2022 → 31 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Proof of concept: immunotherapy in glioblastoma multiforme.From21 Sep 2020 → TodayFunding: FWO fellowships
- Single-Cell Omics to Reveal Mechanisms of Response to Immunotherapy in Head and Neck CancerFrom1 Sep 2019 → 15 Apr 2024Funding: Foundations, funds and other with scientific goal
- Novel applications for immune checkpoint blockers in head and neck cancerFrom1 Sep 2018 → 19 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- Determination of genetic and therapeutic dependencies of patient-derived models of brain cancerFrom1 Oct 2017 → 30 Sep 2021Funding: Fund Recuperation Fiscal Exemption
- A molecular approach to understand breast cancer cell dormancy.From1 Oct 2012 → 4 Jul 2019Funding: FWO fellowships
Publications
1 - 10 of 171
- Single-Cell Omics to Reveal Mechanisms of Response to Immunotherapy in Head and Neck Cancer(2024)
Authors: Amelie Franken, Diether Lambrechts, Paul Clement
- CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy.(2024)
Authors: Amelie Franken, Michel Bila, Aurelie Mechels, Jeroen Van Dessel, Bram Boeckx, Sigrid Hatse, Esther Hauben, Vincent Vander Poorten, Katy Vandereyken, Sabine Tejpar, et al.
Pages: 541 - 558.e7 - The prognostic effect of radiological extranodal extension in HPV-positive oropharyngeal squamous cell carcinomas: a retrospective cohort analysis(2024)
Authors: Jeroen Meulemans, Bob Hermans, Annouschka Laenen, Sandra Nuyts, Paul Clement, Pierre Delaere, Vincent Vander Poorten
- Exploring long-term responses to immune checkpoint inhibitors in recurrent and metastatic head and neck squamous cell carcinoma(2024)
Authors: Michel Bila, Amelie Franken, Jeroen Van Dessel, Jeroen Meulemans, Robin Willaert, Vincent Vander Poorten, Paul Clement
- Germline heterozygous deletion containing CDKN2A/CDKN2B as genetic substrate for rare familial neural and skin tumor syndrome(2024)
Authors: Hilde Brems, Paul Clement, Steven De Vleeschouwer, Frank Van Calenbergh, Eric Legius
Pages: 583 - 583 - Trial watch: chemotherapy-induced immunogenic cell death in oncology(2023)
Authors: Jenny Sprooten, Isaure Vanmeerbeek, Stefan Naulaerts, Lisa Kinget, An Coosemans, Steven De Vleeschouwer, Els Wauters, Sabine Tejpar, Benoit Beuselinck, Sigrid Hatse, et al.
- HUB-RELATED GRAPH METRICS AS MARKER FOR COGNITIVE OUTCOMES IN ADULT GLIOMA SURVIVORS AFTER MULTIMODAL THERAPY(2023)
Authors: Laurien De Roeck, Stefan Sunaert, Patrick Dupont, Paul Clement, Steven De Vleeschouwer, Charlotte Sleurs, Maarten Lambrecht
- Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial(2023)
Authors: Paul Clement
Pages: 3892 - 3900 - Spatial multiome mapping of therapy-induced, pathological changes in glioblastoma at single-cell resolution(2023)
Authors: Francesca Bosisio, Steven De Vleeschouwer, Paul Clement
- Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers(2023)
Authors: Paul Clement